The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.
![fc9eaf08-5d8b-4c20-a73c-516188a3e81a-e1565209824158[1]](https://lexagene.com/wp-content/uploads/2021/11/fc9eaf08-5d8b-4c20-a73c-516188a3e81a-e15652098241581.jpeg)
BioSpace article on LexaGene antibiotic resistance testing
LexaGene
LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.
Upcoming Events
No events in this category to show at this time.
Latest Resources
LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.